| Dr Taras W Didenko, MD | |
|
999 N Plaza Dr Ste 270, Schaumburg, IL 60173-5493 | |
| (847) 496-4525 | |
| (847) 660-2958 |
| Full Name | Dr Taras W Didenko |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 15 Years |
| Location | 999 N Plaza Dr Ste 270, Schaumburg, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699921221 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 125050277 (Illinois) | Primary |
| Entity Name | Taras W Didenko Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982997292 PECOS PAC ID: 1850563909 Enrollment ID: O20111013000435 |
News Archive
ABC News reports that Christina D. Romer, chair of the president's Council of Economic Advisers, "went to bat on Monday for a tax on high-priced insurance plans, the so-called 'Cadillac tax,' calling it 'probably the number one item that health economists across the ideological spectrum believe is likely to stem the explosion of health-care costs.'"
Lexicon Pharmaceuticals, Inc., announced today that top-line data from its Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome (IBS) will be presented at GASTRO 2009 in London this week. Results from the study, which showed a significant improvement in IBS symptoms, will be presented by Dr. Philip M. Brown, Lexicon's senior vice president of clinical development, on November 25, 2009 at 2:30 pm local time at the session entitled, "Therapeutic insights in functional digestive disorders."
"The United Nations estimates the civil war raging in Syria has left more than 2.5 million people in dire need of food, water, drugs and medical supplies," VOA News reports.
On June 15, 2010, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rule 5550(a)(2) and, unless the Company appeals NASDAQ's decision, trading of the Company's common stock will be suspended and the Company's securities will be delisted from the NASDAQ Stock Market.
A major hurdle to using neural stem cells derived from genetically different donors to replace damaged or destroyed tissues, such as in a spinal cord injury, has been the persistent rejection of the introduced material, necessitating the use of complex drugs and techniques to suppress the host's immune response.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Taras W Didenko, MD Po Box 59566, Schaumburg, IL 60159-0566 Ph: (847) 496-4525 | Dr Taras W Didenko, MD 999 N Plaza Dr Ste 270, Schaumburg, IL 60173-5493 Ph: (847) 496-4525 |
News Archive
ABC News reports that Christina D. Romer, chair of the president's Council of Economic Advisers, "went to bat on Monday for a tax on high-priced insurance plans, the so-called 'Cadillac tax,' calling it 'probably the number one item that health economists across the ideological spectrum believe is likely to stem the explosion of health-care costs.'"
Lexicon Pharmaceuticals, Inc., announced today that top-line data from its Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome (IBS) will be presented at GASTRO 2009 in London this week. Results from the study, which showed a significant improvement in IBS symptoms, will be presented by Dr. Philip M. Brown, Lexicon's senior vice president of clinical development, on November 25, 2009 at 2:30 pm local time at the session entitled, "Therapeutic insights in functional digestive disorders."
"The United Nations estimates the civil war raging in Syria has left more than 2.5 million people in dire need of food, water, drugs and medical supplies," VOA News reports.
On June 15, 2010, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rule 5550(a)(2) and, unless the Company appeals NASDAQ's decision, trading of the Company's common stock will be suspended and the Company's securities will be delisted from the NASDAQ Stock Market.
A major hurdle to using neural stem cells derived from genetically different donors to replace damaged or destroyed tissues, such as in a spinal cord injury, has been the persistent rejection of the introduced material, necessitating the use of complex drugs and techniques to suppress the host's immune response.
› Verified 7 days ago
Dr. Anna R Flynn, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1701 E Woodfield Rd, Suite 1000, Schaumburg, IL 60173 Phone: 847-240-2211 Fax: 847-240-2418 | |
Dr. Andrew Martorana, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1900 E Golf Rd, Suite 300, Schaumburg, IL 60173 Phone: 847-585-4856 Fax: 847-585-4040 | |
Dr. Jason Victor Chang, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1701 E Woodfield Road, Suite 1000, Schaumburg, IL 60173 Phone: 847-240-2211 Fax: 847-240-2418 | |
Dr. Donna Marie Woods, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1701 E. Woodfield Road, Suite 1000, Schaumburg, IL 60173 Phone: 847-240-2211 Fax: 847-240-2418 | |
Dr. Michael Rachman, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1375 E Schaumburg Road, Suite 260, Schaumburg, IL 60194 Phone: 847-895-4540 | |
Aleksandar Kondic, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1305 Wiley Rd, 125, Schaumburg, IL 60173 Phone: 847-240-5080 Fax: 847-240-1977 | |
Brian M Mcfaul, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1701 E. Woodfield Road, Suite 1000, Schaumburg, IL 60173 Phone: 847-240-2211 Fax: 847-240-2418 |